Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies - PubMed (original) (raw)
Review
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al. Aging (Albany NY). 2016 Apr.
Abstract
Apoptosis is a form of programmed cell death that results in the orderly and efficient removal of damaged cells, such as those resulting from DNA damage or during development. Apoptosis can be triggered by signals from within the cell, such as genotoxic stress, or by extrinsic signals, such as the binding of ligands to cell surface death receptors. Deregulation in apoptotic cell death machinery is an hallmark of cancer. Apoptosis alteration is responsible not only for tumor development and progression but also for tumor resistance to therapies. Most anticancer drugs currently used in clinical oncology exploit the intact apoptotic signaling pathways to trigger cancer cell death. Thus, defects in the death pathways may result in drug resistance so limiting the efficacy of therapies. Therefore, a better understanding of the apoptotic cell death signaling pathways may improve the efficacy of cancer therapy and bypass resistance. This review will highlight the role of the fundamental regulators of apoptosis and how their deregulation, including activation of anti-apoptotic factors (i.e., Bcl-2, Bcl-xL, etc) or inactivation of pro-apoptotic factors (i.e., p53 pathway) ends up in cancer cell resistance to therapies. In addition, therapeutic strategies aimed at modulating apoptotic activity are briefly discussed.
Keywords: apoptosis; cancer; defective apoptotic pathways; miRNAs; p53; small molecules.
Conflict of interest statement
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Figure 1. Intrinsic and extrinsic apoptotic pathways
The intrinsic (mitochondrial) and the extrinsic (ligands/death receptors) cell death pathways and their convergence through t-Bid are depicted (see text for details)
Figure 2. Bcl-2 family members domain composition and function
Typical BH (Bcl-2 Homology) domains, listed from BH1 to BH4, are shown. TM: transmembrane domain.
Figure 3. Bcl-2 protein subgroups
The Bcl-2 proteins are classified into three subgroups, one group with anti-apoptotic and two with pro-apoptotic function, depending on the composition of the typical BH domains, listed from BH1 to BH4. Representative members of each subfamily are shown.
Figure 4. Function of inhibitors of apoptosis proteins (IAPs)
IAPs are often overexpressed in cancer and they have the ability to bind and inactivate caspases 9 and 3. The activities of IAPs, on the other hand, may be suppressed by mitochondrial proteins, such as Omi/HtrA2 and Smac/DIABLO, released into the cytosol during apoptosis.
Figure 5. Mechanisms leading to deregulation of apoptosis
Schematic representation of the different ways through which both the extrinsic and the intrinsic apoptotic pathways may be altered, resulting in reduction of apoptosis or acquisition of apoptosis resistance.
Figure 6. p53-mediated apoptosis
Role of p53 in both the extrinsic and the intrinsic pathway and their convergence through t-Bid.
Similar articles
- Cancer and Apoptosis.
Chaudhry GE, Akim AM, Sung YY, Muhammad TST. Chaudhry GE, et al. Methods Mol Biol. 2022;2543:191-210. doi: 10.1007/978-1-0716-2553-8_16. Methods Mol Biol. 2022. PMID: 36087269 - Changes in the apoptotic and survival signaling in cancer cells and their potential therapeutic implications.
Kabore AF, Johnston JB, Gibson SB. Kabore AF, et al. Curr Cancer Drug Targets. 2004 Mar;4(2):147-63. doi: 10.2174/1568009043481551. Curr Cancer Drug Targets. 2004. PMID: 15032666 Review. - Apoptotic cell signaling in cancer progression and therapy.
Plati J, Bucur O, Khosravi-Far R. Plati J, et al. Integr Biol (Camb). 2011 Apr;3(4):279-96. doi: 10.1039/c0ib00144a. Epub 2011 Feb 22. Integr Biol (Camb). 2011. PMID: 21340093 Free PMC article. Review. - Apoptotic pathways in tumor progression and therapy.
Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R. Melet A, et al. Adv Exp Med Biol. 2008;615:47-79. doi: 10.1007/978-1-4020-6554-5_4. Adv Exp Med Biol. 2008. PMID: 18437891 Review. - Apoptosis: molecular mechanisms and implications for cancer chemotherapy.
Guchelaar HJ, Vermes A, Vermes I, Haanen C. Guchelaar HJ, et al. Pharm World Sci. 1997 Jun;19(3):119-25. doi: 10.1023/a:1008654316572. Pharm World Sci. 1997. PMID: 9259027 Review.
Cited by
- Potential of Resveratrol to Combine with Hydrogel for Photodynamic Therapy against Bacteria and Cancer-A Review.
Law SK, Liu CWC, Tong CWS, Au DCT. Law SK, et al. Biomedicines. 2024 Sep 13;12(9):2095. doi: 10.3390/biomedicines12092095. Biomedicines. 2024. PMID: 39335608 Free PMC article. Review. - Different Cytotoxicity Induced by Hexabromocyclododecanes on Mouse Neuroblastoma N2a Cells via Oxidative Stress and Mitochondrial Apoptotic Pathway.
Wan K, Wu D, Xie G, Li Y, Zhang J. Wan K, et al. Toxics. 2024 Sep 12;12(9):665. doi: 10.3390/toxics12090665. Toxics. 2024. PMID: 39330593 Free PMC article. - Investigating the molecular mechanisms of Fuzheng Yiliu Shenji prescription in SH-SY5Y neuroblastoma cells.
Zhu X, Si Y, Gai C, Li Z. Zhu X, et al. Front Oncol. 2024 Sep 10;14:1447666. doi: 10.3389/fonc.2024.1447666. eCollection 2024. Front Oncol. 2024. PMID: 39319058 Free PMC article. - Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis.
Cai K, Fang Y, Zhang Y, Liu J, Ye Q, Ding L, Cai X. Cai K, et al. PLoS One. 2024 Sep 20;19(9):e0310391. doi: 10.1371/journal.pone.0310391. eCollection 2024. PLoS One. 2024. PMID: 39302935 Free PMC article. - EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory protein.
Guo R, Wei Y, Du Y, Liu L, Zhang H, Ren R, Sun R, Zhang T, Xiong X, Zhao L, Wang H, Guo X, Zhu X. Guo R, et al. Cancer Biol Ther. 2024 Dec 31;25(1):2402588. doi: 10.1080/15384047.2024.2402588. Epub 2024 Sep 17. Cancer Biol Ther. 2024. PMID: 39286953 Free PMC article.
References
- Fulda S. Tumor resistance to apoptosis. Int J Cancer. 2009;124:515–515. - PubMed
- Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646–674. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous